Plant ID: NPO16230
Plant Latin Name: Malus pumila
Taxonomy Genus: Malus
Taxonomy Family: Rosaceae
NCBI TaxonomyDB:
283210
Plant-of-the-World-Online:
n.a.
Anthelmintic; Antibacterial; Bach; Hypnotic; Refrigerant
India; Italy; China
TDP1; RECQL; ALDH1A1; BRCA1; | |
MMP2; MMP9; MMP1; | |
SLCO1B3; SLCO1B1; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | BRCA1 | Breast cancer type 1 susceptibility protein | P38398 | CHEMBL5990 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0030574; collagen catabolic process | 3.011E-06 | 3.058E-02 | MMP1, MMP2, MMP9 |
BP | GO:0009987; cellular process | GO:0022617; extracellular matrix disassembly | 5.434E-06 | 3.058E-02 | MMP1, MMP2, MMP9 |
BP | Unclassified; | GO:0044259; multicellular organismal macromolecule metabolic process | 7.021E-06 | 3.058E-02 | MMP1, MMP2, MMP9 |
BP | Unclassified; | GO:0044236; multicellular organism metabolic process | 1.317E-05 | 4.781E-02 | MMP1, MMP2, MMP9 |
MF | GO:0003824; catalytic activity | GO:0004222; metalloendopeptidase activity | 1.682E-05 | 5.233E-02 | MMP1, MMP2, MMP9 |
MF | GO:0005215; transporter activity | GO:0015125; bile acid transmembrane transporter activity | 2.941E-05 | 8.006E-02 | SLCO1B1, SLCO1B3 |
BP | GO:0008283; cell proliferation | GO:1904707; positive regulation of vascular smooth muscle cell proliferation | 4.436E-05 | 1.073E-01 | MMP2, MMP9 |
BP | GO:0009987; cellular process | GO:0006302; double-strand break repair | 5.507E-05 | 1.090E-01 | BRCA1, RECQL, TDP1 |
MF | GO:0005215; transporter activity | GO:0015347; sodium-independent organic anion transmembrane transporter activity | 5.298E-05 | 1.090E-01 | SLCO1B1, SLCO1B3 |
BP | GO:0051179; localization | GO:0043252; sodium-independent organic anion transport | 7.249E-05 | 1.153E-01 | SLCO1B1, SLCO1B3 |
MF | GO:0003824; catalytic activity | GO:0004252; serine-type endopeptidase activity | 1.659E-04 | 2.007E-01 | MMP1, MMP2, MMP9 |
CC | GO:0044421; extracellular region part | GO:0005578; proteinaceous extracellular matrix | 2.373E-04 | 2.318E-01 | MMP1, MMP2, MMP9 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 3.313E-04 | 2.774E-01 | BRCA1, MMP1, MMP2, MMP9 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 3.176E-03 | 9.424E-01 | SLCO1B1, SLCO1B3 |
CC | GO:0016020; membrane | GO:0005886; plasma membrane | 3.365E-02 | 1.000E+00 | BRCA1, MMP2, SLCO1B1, SLCO1B3, TDP1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 6.660E-07 | 1.265E-05 | MMP1, MMP2, MMP9 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 5.965E-04 | 3.778E-03 | MMP1, MMP2, MMP9 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 4.402E-04 | 3.778E-03 | SLCO1B1, SLCO1B3 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 8.537E-04 | 4.055E-03 | MMP2, MMP9 |
09150 Organismal Systems | 09151 Immune system | hsa04670 | Leukocyte transendothelial migration | 1.209E-03 | 4.596E-03 | MMP2, MMP9 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 3.521E-03 | 1.115E-02 | MMP2, MMP9 |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 7.385E-03 | 2.005E-02 | BRCA1, MMP9 |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03460 | Fanconi anemia pathway | 2.360E-02 | 5.606E-02 | BRCA1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.888E-02 | 5.820E-02 | ALDH1A1 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 3.063E-02 | 5.820E-02 | MMP1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | MMP9; |
C00-D49: Neoplasms | Renal cell carcinoma | NA | MMP2; |
K00-K95: Diseases of the digestive system | Ulcerative colitis | K51 | MMP9; |
C00-D49: Neoplasms | Cancer | C00-C96 | MMP9; MMP2; |
C00-D49: Neoplasms | Lung cancer | C33-C34 | MMP2; |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2; |
I00-I99: Diseases of the circulatory system | Stroke | I61-I63, I80-I82 | MMP9; |
L00-L99: Diseases of the skin and subcutaneous tissue | Acne vulgaris | L70.0 | MMP2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP2; |
C00-D49: Neoplasms | Ovarian cancer | C56 | MMP2; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MMP9; MMP2; |